Preparation and Applications of Organo-Silica Hybrid Mesoporous Silica Nanoparticles for the Co-Delivery of Drugs and Nucleic Acids
Combination therapies rely on the administration of more than one drug, with independent mechanisms of action, aiming to enhance the efficiency of the treatment. For an optimal performance, the implementation of such therapies requires the delivery of the correct combination of drugs to a specific c...
Main Authors: | Iris Pontón, Andrea Martí del Rio, Marta Gómez Gómez, David Sánchez-García |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/10/12/2466 |
Similar Items
-
Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications
by: Wenzhang Cha, et al.
Published: (2017-05-01) -
Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review
by: Juan L. Paris, et al.
Published: (2020-06-01) -
Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment
by: Eleen Dayana Mohamed Isa, et al.
Published: (2021-01-01) -
Recent Advances Toward the Use of Mesoporous Silica Nanoparticles for the Treatment of Bacterial Infections
by: Castillo RR, et al.
Published: (2021-06-01) -
Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer
by: Anna Watermann, et al.
Published: (2017-07-01)